%D8%B3%D9%8A%D9%81%D9%85%D9%8A%D9%86%D9%88%D9%83%D8%B3%D9%8A%D9%85Cefmenoxime%D8%B3%D9%81%D9%85%D9%86%D9%88%DA%A9%D8%B3%DB%8C%D9%85CefmenoksimCefmenoksim%E0%B9%80%E0%B8%8B%E0%B8%9F%E0%B8%A1%E0%B8%B5%E0%B8%99%E0%B8%AD%E0%B8%81%E0%B8%8B%E0%B8%B4%E0%B8%A1CefmenoximeQ4921166%E5%A4%B4%E5%AD%A2%E7%94%B2%E8%82%9F
about
Pharmacoeconomic analysis of cefmenoxime dual individualization in the treatment of nosocomial pneumoniaCefmenoxime in corneal organ cultureEpitope analysis of aztreonam by antiaztreonam monoclonal antibodies and possible consequences in beta-lactams hypersensitivityComparative in vitro susceptibilities of anaerobic bacteria to cefmenoxime, cefotetan, and N-formimidoyl thienamycin.Beta-lactamase stability and antibacterial activity of cefmenoxime (SCE-1365), a novel cephalosporin.Comparative in vitro activities of cefmenoxime (SCE-1365) and newer cephalosporin derivatives of clinical utilityAntimicrobial activity of cefmenoxime compared with those of other cephalosporins.Cross-reactivity in β-Lactam Allergy.Contact urticaria syndrome with IgE antibody against a cefotiam-unique structure, evoked by nonapparent exposure to cefotiam.Laboratory evaluation of cefmenoxime: a new cephalosporin. In vitro and in vivo antibacterial activities and pharmacokinetic propertiesPenetration of cefmenoxime into serum, gynecologic tissues, and heart valves
P921
Q28254231-2E1D6DD1-65FA-4847-AEAE-436B41B87EA0Q28305157-BF5CF5D7-392E-45F2-9A73-4A53B0F20F21Q28316455-359106DC-7702-4FA1-8753-BF6235628C2CQ35740560-E417740F-5939-4589-BA84-D4633842DD90Q39855537-1C295E75-AE94-45FF-B99D-C845B713BD12Q39857303-4E5E0F2B-1899-49CF-BD2C-625ED8C2ECABQ41895847-DCC539A5-F6C5-4A39-9A43-2FF11B17E498Q41987583-FC20D516-105C-4944-9518-576920536B6FQ53701678-C767F675-34CB-4C0B-831A-FAAF88A53221Q67284842-A308C58A-4DD6-4CCC-91AE-940B4CA941D7Q72407783-71A5925D-8D08-40D3-B9D7-E0A8BFBB20A7
P921
description
chemesch Verbindung
@lb
chemical compound
@en
chemical compound
@en-ca
chemical compound
@en-gb
chemická sloučenina
@cs
chemická zlúčenina
@sk
chemiese verbinding
@af
chemische Verbindung
@de
chemische Verbindung
@de-ch
chemische verbinding
@nl
name
Cefmenoksim
@sh
Cefmenoksim
@sr
Cefmenoxime
@vi
cefmenoxime
@en
سفمنوکسیم
@fa
سيفمينوكسيم
@ar
เซฟมีนอกซิม
@th
头孢甲肟
@zh
头孢甲肟
@zh-hans
頭孢甲肟
@zh-hant
type
label
Cefmenoksim
@sh
Cefmenoksim
@sr
Cefmenoxime
@vi
cefmenoxime
@en
سفمنوکسیم
@fa
سيفمينوكسيم
@ar
เซฟมีนอกซิม
@th
头孢甲肟
@zh
头孢甲肟
@zh-hans
頭孢甲肟
@zh-hant
altLabel
(6R,7R)-7-((Z)-2-(2-Amino-4-th ...... (4.2.0)oct-2-en-2-carbonsaeure
@en
(6R,7R)-7-[[(2e)-2-(2-amino-1, ...... -ene-2-carboxylic acid (iupac)
@en
Cefmenoxima
@en
Cefmenoxime
@ar
Cefmenoxime
@en
Cefmenoximum
@en
السيفمينوكسيم
@ar
倍司特克
@zh
噻肟唑头孢
@zh
头孢噻肟四唑
@zh
prefLabel
Cefmenoksim
@sh
Cefmenoksim
@sr
Cefmenoxime
@vi
cefmenoxime
@en
سفمنوکسیم
@fa
سيفمينوكسيم
@ar
เซฟมีนอกซิม
@th
头孢甲肟
@zh
头孢甲肟
@zh-hans
頭孢甲肟
@zh-hant
P486
P592
P6366
P661
P662
P665
P6694
P683
P1579
P2017
CN1C(=NN=N1)SCC2=C(N3[C@@H]([C@@H](C3=O)NC(=O)/C(=N\OC)/C4=CSC(=N4)N)SC2)C(=O)O
P2067
511.051478
P2275
cefmenoxime
@en
cefmenoximum
@en
P231
65085-01-0
P233
CN1C(=NN=N1)SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)O
P234
1S/C16H17N9O5S3/c1-24-16(20-22 ...... (H,28,29)/b21-8-/t9-,13-/m1/s1
P235
HJJDBAOLQAWBMH-YCRCPZNHSA-N